new treatment for joint disease: a seminar on october 19 in bOLOGNA provides update on future research

Osteoarthritis is a joint disease becoming more prevalent in adults as a leading cause of disability and an increasing contribution to financial burden for health-care systems. These topics, together with the pathogenesis of pain, articular cartilage repair and the possibility of altering disease progression are the focus of the seminar “L’articolazione tra presente e futuro. Capire, conoscere e curare”, being held in Bologna on October 19 from 9,30 am at the Istituto Ortopedico Rizzoli (Aula Anfiteatro - Via di Barbiano).

Along with recent research on prevention and a focus on core treatments, experts from AMRER association (Associazione Malati Reumatici Emilia Romagna), doctors of the Istituto Ortopedico Rizzoli (IOR) and engineers from the Sant’Anna School Biorobotics Institute working on the EU funded project ADMAIORA (ADvanced nanocomposite MAterIals fOr in situ treatment and ultRAsoundmediated management of osteoarthritis), will meet with representatives of Bologna City Council authority to discuss appropriate therapies  and future research on osteoarthritis.

The seminar provides an update on the most promising treatments and summarizes the evidence of recent clinical studies in tissue repair and regeneration. Ageing and obesity in the European Union and global population will result in the rise of osteoarthritis. It is estimated (UN report) that in 2050, over 130 million people will be affected and osteoarthritis will be a major cause of disability among the elderly (40 million individuals affected).

The seminar participants will include: Mario Cavalli (Istituto Ortopedico Rizzoli), Guerrina Filippi (AMRER Onlus), doctors and experts  Riccardo Meliconi, Mariada Perrone, Stefano Zaffagnini , Alessandro Russo, Mariagrazia Benedetti, Mariela Terrafino, and  Giovanni Ciancio (Aosp–Ferrara).

Researchers Gina Lisignoli (Istituto Ortopedico Rizzoli) and Leonardo Ricotti (Sant’Anna School Biorobotics Institute) will explore the ADMAIORA current research to combine regenerative therapy and ultrasound mediated targeted therapy as a novel strategy to restore structure and function of damaged cartilage.

The four-year project ADMAIORA, bringing together eighth European partners, focuses on the development of tissue engineering involving bioactive factors and cells implantation for articular cartilage repair.

The event is free and open to the public. Please click here for online registration.